These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9122237)

  • 21. Platelet-activating factor augments tumor necrosis factor and procoagulant activity.
    Maier RV; Hahnel GB; Fletcher JR
    J Surg Res; 1992 Mar; 52(3):258-64. PubMed ID: 1538603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of in vivo 'priming' on endotoxin-induced hypotension and tissue injury. The role of PAF and tumor necrosis factor.
    Sun XM; Hsueh W; Torre-Amione G
    Am J Pathol; 1990 Apr; 136(4):949-56. PubMed ID: 2327475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of rabbit C-reactive protein in transgenic mice inhibits development of antigen-induced arthritis.
    Jiang S; Xia D; Samols D
    Scand J Rheumatol; 2006; 35(5):351-5. PubMed ID: 17062433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer.
    Toniatti C; Arcone R; Majello B; Ganter U; Arpaia G; Ciliberto G
    Mol Biol Med; 1990 Jun; 7(3):199-212. PubMed ID: 2170808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in bronchial responsiveness, circulating leucocytes and ex vivo cytokine production by blood monocytes after PAF inhalation in allergic asthmatics.
    Louis R; Degroote D; Bury T; Corhay JL; Kayembe JM; Franchimont P; Radermecker MF
    Eur Respir J; 1995 Apr; 8(4):611-8. PubMed ID: 7664863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
    Dubois C; Bissonnette E; Rola-Pleszczynski M
    J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.
    Li N; Klaassen CD
    Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
    Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
    Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response.
    Memon RA; Fuller J; Moser AH; Feingold KR; Grunfeld C
    Am J Physiol; 1999 Jul; 277(1):R94-103. PubMed ID: 10409262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself.
    Pepys MB; Hawkins PN; Kahan MC; Tennent GA; Gallimore JR; Graham D; Sabin CA; Zychlinsky A; de Diego J
    Circ Res; 2005 Nov; 97(11):e97-103. PubMed ID: 16254214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F; Decker K
    Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: comparison between tumor necrosis factor alpha and beta and interleukin-1.
    Bussolino F; Camussi G; Tetta C; Garbarino G; Bosia A; Baglioni C
    J Lipid Mediat; 1990; 2 Suppl():S15-22. PubMed ID: 2133280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbit blastocysts accumulate platelet-activating factor (PAF) and lyso-PAF in vitro.
    Jones MA; Kudolo GB; Harper MJ
    Mol Reprod Dev; 1992 Jul; 32(3):243-50. PubMed ID: 1323306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor and its metabolite promote sleep in rabbits.
    Kushikata T; Fang J; Krueger JM
    Neurosci Lett; 2006 Feb; 394(3):233-8. PubMed ID: 16263215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.
    Fernandes ES; Passos GF; Campos MM; de Souza GE; Fittipaldi JF; Pesquero JL; Teixeira MM; Calixto JB
    Br J Pharmacol; 2005 Sep; 146(2):209-16. PubMed ID: 16025141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.
    Szalai AJ; van Ginkel FW; Dalrymple SA; Murray R; McGhee JR; Volanakis JE
    J Immunol; 1998 Jun; 160(11):5294-9. PubMed ID: 9605127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-activating factor (PAF-acether) enhances the concomitant production of tumour necrosis factor-alpha and interleukin-1 by subsets of human monocytes.
    Poubelle PE; Gingras D; Demers C; Dubois C; Harbour D; Grassi J; Rola-Pleszczynski M
    Immunology; 1991 Feb; 72(2):181-7. PubMed ID: 2016118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.
    Sun XM; Hsueh W
    J Clin Invest; 1988 May; 81(5):1328-31. PubMed ID: 3366898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
    He J; Bazan HE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.